Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 151
of 8Next
1:

B cell targeted therapies.

Keystone E.

Arthritis Res Ther. 2005;7 Suppl 3:S13-8. Epub 2005 May 18. Review.

PMID: 15960817 [PubMed - indexed for MEDLINE]

2:

B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.

Looney RJ.

Drugs. 2006;66(5):625-39. Review.

PMID: 16620141 [PubMed - indexed for MEDLINE]

3:

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID: 17100405 [PubMed - indexed for MEDLINE]

4:

Updates from B Cell Trials: Efficacy.

Cohen SB.

J Rheumatol Suppl. 2006 May;77:12-7. Review.

PMID: 16652440 [PubMed - indexed for MEDLINE]

5:

What is the role of rituximab in the treatment of rheumatoid arthritis?

Atzeni F, Doria A, Maurizio T, Sarzi-Puttini P.

Autoimmun Rev. 2007 Sep;6(8):553-8. Epub 2007 Mar 7. Review.

PMID: 17854748 [PubMed - indexed for MEDLINE]

6:

B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.

Eisenberg R, Albert D.

Nat Clin Pract Rheumatol. 2006 Jan;2(1):20-7. Review.

PMID: 16932648 [PubMed - indexed for MEDLINE]

7:

Improvement of refractory rheumatoid arthritis after depletion of B cells.

Kneitz C, Wilhelm M, Tony HP.

Scand J Rheumatol. 2004;33(2):82-6.

PMID: 15163108 [PubMed - indexed for MEDLINE]

8:

B cell targeted therapies: safety considerations.

Kavanaugh AF.

J Rheumatol Suppl. 2006 May;77:18-23. Review.

PMID: 16652441 [PubMed - indexed for MEDLINE]

10:

Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.

Dörner T.

J Rheumatol Suppl. 2006 May;77:3-11. Review.

PMID: 16652439 [PubMed - indexed for MEDLINE]

11:

Targeted therapy in rheumatoid arthritis.

Köller MD.

Wien Med Wochenschr. 2006 Jan;156(1-2):53-60. Review.

PMID: 16465614 [PubMed - indexed for MEDLINE]

12:

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.

De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G.

Arthritis Rheum. 2002 Aug;46(8):2029-33.

PMID: 12209504 [PubMed - indexed for MEDLINE]

14:

B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.

Edwards JC, Leandro MJ, Cambridge G.

Curr Dir Autoimmun. 2005;8:175-92.

PMID: 15564721 [PubMed - indexed for MEDLINE]

15:

B cell-directed therapy in rheumatoid arthritis--clinical experience.

Panayi GS.

J Rheumatol Suppl. 2005 Feb;73:19-24; discussion 29-30. Review.

PMID: 15693112 [PubMed - indexed for MEDLINE]

16:

Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.

Goldblatt F, Isenberg DA.

Handb Exp Pharmacol. 2008;(181):163-81. Review.

PMID: 18071946 [PubMed - indexed for MEDLINE]

17:

Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.

Vallerskog T, Heimbürger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C, Malmström V.

Arthritis Res Ther. 2006;8(6):R167.

PMID: 17092341 [PubMed - indexed for MEDLINE]

18:

[B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis]

Yukawa N, Mimori T.

Clin Calcium. 2007 Apr;17(4):569-76. Review. Japanese.

PMID: 17404487 [PubMed - indexed for MEDLINE]

19:

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.

Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC.

Arthritis Rheum. 2006 Feb;54(2):613-20.

PMID: 16447239 [PubMed - indexed for MEDLINE]

20:

B cells in rheumatoid arthritis: from hypothesis to the clinic.

Keystone EC.

Rheumatology (Oxford). 2005 May;44 Suppl 2:ii8-ii12. Review.

PMID: 15851525 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 151
of 8Next